Literature DB >> 26235622

Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative Proliferation.

Kevin Myant1, Xi Qiao2, Tuuli Halonen3, Christophe Come3, Anni Laine3, Mahnaz Janghorban4, Johanna I Partanen5, John Cassidy1, Erinn-Lee Ogg1, Patrizia Cammareri1, Tiina Laiterä3, Juha Okkeri3, Juha Klefström5, Rosalie C Sears4, Owen J Sansom6, Jukka Westermarck7.   

Abstract

An understanding of the mechanisms determining MYC's transcriptional and proliferation-promoting activities in vivo could facilitate approaches for MYC targeting. However, post-translational mechanisms that control MYC function in vivo are poorly understood. Here, we demonstrate that MYC phosphorylation at serine 62 enhances MYC accumulation on Lamin A/C-associated nuclear structures and that the protein phosphatase 2A (PP2A) inhibitor protein CIP2A is required for this process. CIP2A is also critical for serum-induced MYC phosphorylation and for MYC-elicited proliferation induction in vitro. Complementary transgenic approaches and an intestinal regeneration model further demonstrated the in vivo importance of CIP2A and serine 62 phosphorylation for MYC activity upon DNA damage. However, targeting of CIP2A did not influence the normal function of intestinal crypt cells. These data underline the importance of nuclear organization in the regulation of MYC phosphorylation, leading to an in vivo demonstration of a strategy for inhibiting MYC activity without detrimental physiological effects.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26235622      PMCID: PMC4535171          DOI: 10.1016/j.celrep.2015.07.003

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  48 in total

1.  Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration.

Authors:  Ciara Metcalfe; Noelyn M Kljavin; Ryan Ybarra; Frederic J de Sauvage
Journal:  Cell Stem Cell       Date:  2013-12-12       Impact factor: 24.633

Review 2.  Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target.

Authors:  Anchit Khanna; John E Pimanda; Jukka Westermarck
Journal:  Cancer Res       Date:  2013-11-07       Impact factor: 12.701

Review 3.  Multiple facets of nuclear periphery in gene expression control.

Authors:  Ghislaine Arib; Asifa Akhtar
Journal:  Curr Opin Cell Biol       Date:  2011-01-15       Impact factor: 8.382

Review 4.  Nuclear pore complexes in the maintenance of genome integrity.

Authors:  Lucas Bukata; Stephanie L Parker; Maximiliano A D'Angelo
Journal:  Curr Opin Cell Biol       Date:  2013-04-06       Impact factor: 8.382

Review 5.  Nuclear pore complexes: guardians of the nuclear genome.

Authors:  M Capelson; C Doucet; M W Hetzer
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-04-18

6.  Identification of CRM1-dependent Nuclear Export Cargos Using Quantitative Mass Spectrometry.

Authors:  Ketan Thakar; Samir Karaca; Sarah A Port; Henning Urlaub; Ralph H Kehlenbach
Journal:  Mol Cell Proteomics       Date:  2012-12-13       Impact factor: 5.911

7.  Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.

Authors:  Amy S Farrell; Carl Pelz; Xiaoyan Wang; Colin J Daniel; Zhiping Wang; Yulong Su; Mahnaz Janghorban; Xiaoli Zhang; Charlie Morgan; Soren Impey; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

8.  CIP2A modulates cell-cycle progression in human cancer cells by regulating the stability and activity of Plk1.

Authors:  Jae-Sung Kim; Eun Ju Kim; Jeong Su Oh; In-Chul Park; Sang-Gu Hwang
Journal:  Cancer Res       Date:  2013-08-27       Impact factor: 12.701

9.  CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance.

Authors:  Sami Ventelä; Eleonora Sittig; Leni Mannermaa; Juho-Antti Mäkelä; Jarmo Kulmala; Eliisa Löyttyniemi; Leena Strauss; Olli Cárpen; Jorma Toppari; Reidar Grénman; Jukka Westermarck
Journal:  Oncotarget       Date:  2015-01-01

10.  CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation.

Authors:  Pietri Puustinen; Anna Rytter; Monika Mortensen; Pekka Kohonen; José M Moreira; Marja Jäättelä
Journal:  J Cell Biol       Date:  2014-03-03       Impact factor: 10.539

View more
  27 in total

Review 1.  Causes and consequences of nuclear envelope alterations in tumour progression.

Authors:  Emily S Bell; Jan Lammerding
Journal:  Eur J Cell Biol       Date:  2016-06-25       Impact factor: 4.492

2.  Stabilization of nuclear oncoproteins by RNF4 and the ubiquitin system in cancer.

Authors:  M Diefenbacher; A Orian
Journal:  Mol Cell Oncol       Date:  2016-11-18

3.  Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1.

Authors:  Otto Kauko; Susumu Y Imanishi; Evgeny Kulesskiy; Laxman Yetukuri; Teemu Daniel Laajala; Mukund Sharma; Karolina Pavic; Anna Aakula; Christian Rupp; Mikael Jumppanen; Pekka Haapaniemi; Luyao Ruan; Bhagwan Yadav; Veronika Suni; Taru Varila; Garry L Corthals; Jüri Reimand; Krister Wennerberg; Tero Aittokallio; Jukka Westermarck
Journal:  J Biol Chem       Date:  2020-02-18       Impact factor: 5.157

4.  SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.

Authors:  Xiao-Xin Sun; Yingxiao Chen; Yulong Su; Xiaoyan Wang; Krishna Mohan Chauhan; Juan Liang; Colin J Daniel; Rosalie C Sears; Mu-Shui Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-10       Impact factor: 11.205

5.  HiPLA: High-throughput imaging proximity ligation assay.

Authors:  Leonid A Serebryannyy; Tom Misteli
Journal:  Methods       Date:  2018-11-10       Impact factor: 3.608

6.  Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56.

Authors:  Jiao Wang; Juha Okkeri; Karolina Pavic; Zhizhi Wang; Otto Kauko; Tuuli Halonen; Grzegorz Sarek; Päivi M Ojala; Zihe Rao; Wenqing Xu; Jukka Westermarck
Journal:  EMBO Rep       Date:  2017-02-07       Impact factor: 8.807

7.  T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62.

Authors:  Colin J Daniel; Carl Pelz; Xiaoyan Wang; Michael W Munks; Aaron Ko; Dhaarini Murugan; Sarah A Byers; Eleonora Juarez; Karyn L Taylor; Guang Fan; Lisa M Coussens; Jason M Link; Rosalie C Sears
Journal:  Mol Cancer Res       Date:  2022-07-06       Impact factor: 6.333

8.  CIP2A regulates MYC translation (via its 5'UTR) in colorectal cancer.

Authors:  S Denk; S Schmidt; Y Schurr; G Schwarz; F Schote; M Diefenbacher; C Armendariz; F Dejure; M Eilers; Armin Wiegering
Journal:  Int J Colorectal Dis       Date:  2020-10-19       Impact factor: 2.571

Review 9.  MYC Modulation around the CDK2/p27/SKP2 Axis.

Authors:  Per Hydbring; Alina Castell; Lars-Gunnar Larsson
Journal:  Genes (Basel)       Date:  2017-06-30       Impact factor: 4.096

10.  CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.

Authors:  Anni Laine; Srikar G Nagelli; Caroline Farrington; Umar Butt; Anna N Cvrljevic; Julia P Vainonen; Femke M Feringa; Tove J Grönroos; Prson Gautam; Sofia Khan; Harri Sihto; Xi Qiao; Karolina Pavic; Denise C Connolly; Pauliina Kronqvist; Laura L Elo; Jochen Maurer; Krister Wennerberg; Rene H Medema; Heikki Joensuu; Emilia Peuhu; Karin de Visser; Goutham Narla; Jukka Westermarck
Journal:  Cancer Res       Date:  2021-06-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.